Barclays PLC Buys 54,920 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Barclays PLC grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 21.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 306,809 shares of the medical instruments supplier's stock after buying an additional 54,920 shares during the period. Barclays PLC owned 0.15% of DENTSPLY SIRONA worth $8,301,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. UMB Bank n.a. raised its holdings in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock valued at $25,000 after acquiring an additional 753 shares in the last quarter. Capital Performance Advisors LLP bought a new stake in DENTSPLY SIRONA during the third quarter valued at approximately $27,000. LRI Investments LLC lifted its position in DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Kennebec Savings Bank purchased a new position in DENTSPLY SIRONA in the 3rd quarter worth approximately $35,000. Finally, Rothschild Investment LLC purchased a new stake in shares of DENTSPLY SIRONA during the 2nd quarter valued at $32,000. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Trading Down 2.7 %

DENTSPLY SIRONA stock traded down $0.51 during trading hours on Wednesday, reaching $18.68. The stock had a trading volume of 2,946,181 shares, compared to its average volume of 3,099,563. The company has a fifty day simple moving average of $21.07 and a 200-day simple moving average of $24.04. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $37.60. The stock has a market cap of $3.71 billion, a PE ratio of -9.02, a PEG ratio of 1.93 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company had revenue of $951.00 million for the quarter, compared to analysts' expectations of $939.10 million. During the same period last year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA's quarterly revenue was up .4% on a year-over-year basis. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.43%. DENTSPLY SIRONA's dividend payout ratio is presently -30.92%.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on XRAY. Morgan Stanley dropped their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research note on Tuesday. StockNews.com downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Tuesday, November 19th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a research report on Friday, November 8th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a report on Tuesday, December 3rd. Finally, Barrington Research cut their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday, November 8th. Eight investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $27.91.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.